IRIS
MONTIRONI, Rodolfo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 31.971
EU - Europa 16.763
AS - Asia 8.762
SA - Sud America 1.203
AF - Africa 365
Continente sconosciuto - Info sul continente non disponibili 54
OC - Oceania 11
Totale 59.129
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 31.841
UA - Ucraina 3.824
SG - Singapore 2.828
IE - Irlanda 2.233
RU - Federazione Russa 2.225
TR - Turchia 1.913
HK - Hong Kong 1.869
DE - Germania 1.781
SE - Svezia 1.774
DK - Danimarca 1.435
IT - Italia 1.416
BR - Brasile 1.108
CN - Cina 1.039
FI - Finlandia 798
KR - Corea 778
GB - Regno Unito 587
FR - Francia 471
CI - Costa d'Avorio 263
IN - India 140
MX - Messico 66
BE - Belgio 53
EU - Europa 52
CA - Canada 49
MA - Marocco 47
AR - Argentina 28
NL - Olanda 26
ZA - Sudafrica 23
EE - Estonia 21
UZ - Uzbekistan 20
IQ - Iraq 19
JP - Giappone 19
VN - Vietnam 19
AT - Austria 18
PK - Pakistan 18
RO - Romania 18
ES - Italia 17
ID - Indonesia 15
CO - Colombia 13
EC - Ecuador 13
BD - Bangladesh 11
EG - Egitto 11
PL - Polonia 11
VE - Venezuela 11
PE - Perù 9
AE - Emirati Arabi Uniti 8
AU - Australia 8
AZ - Azerbaigian 8
CH - Svizzera 8
KE - Kenya 8
PY - Paraguay 8
OM - Oman 7
AL - Albania 6
BO - Bolivia 6
IL - Israele 6
BG - Bulgaria 5
CZ - Repubblica Ceca 5
KZ - Kazakistan 5
LB - Libano 5
RS - Serbia 5
TN - Tunisia 5
GR - Grecia 4
KG - Kirghizistan 4
UY - Uruguay 4
AM - Armenia 3
BH - Bahrain 3
CL - Cile 3
DO - Repubblica Dominicana 3
HU - Ungheria 3
JM - Giamaica 3
LU - Lussemburgo 3
NP - Nepal 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
SA - Arabia Saudita 3
SK - Slovacchia (Repubblica Slovacca) 3
AO - Angola 2
BY - Bielorussia 2
GE - Georgia 2
GT - Guatemala 2
HN - Honduras 2
IR - Iran 2
IS - Islanda 2
JO - Giordania 2
KH - Cambogia 2
LV - Lettonia 2
LY - Libia 2
PA - Panama 2
PH - Filippine 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
CY - Cipro 1
DZ - Algeria 1
GA - Gabon 1
HR - Croazia 1
IM - Isola di Man 1
LI - Liechtenstein 1
MN - Mongolia 1
Totale 59.121
Salva come PNG Salva come JPEG
Città #
Jacksonville 3.923
Chandler 3.301
Fairfield 3.240
Dublin 2.229
Boardman 2.072
Ashburn 1.924
Hong Kong 1.853
Des Moines 1.850
Wilmington 1.761
Woodbridge 1.433
Singapore 1.324
Seattle 1.260
Houston 1.238
Cambridge 1.007
Lawrence 907
Princeton 907
San Mateo 891
New York 798
Ann Arbor 600
Moscow 490
San Diego 418
Centro 415
The Dalles 310
Abidjan 263
Milan 239
London 153
Beijing 128
Pune 125
São Paulo 101
Shanghai 100
Norwalk 93
Washington 91
Guangzhou 87
Los Angeles 82
Redmond 75
Wuhan 74
Izmir 68
Helsinki 66
Falls Church 61
Dallas 60
Mexico City 52
Brussels 51
Marche 48
Turin 45
Kilburn 44
Rome 37
Jiaxing 36
Ancona 34
Venice 30
Belo Horizonte 29
Rio de Janeiro 27
Seoul 27
Porto 26
Prescot 26
Wuxi 24
Yiwu 22
Fayetteville 20
New Bedfont 20
Shenzhen 20
Tappahannock 20
Munich 19
Brasília 18
Chicago 18
Nuremberg 18
Ottawa 18
Tashkent 18
Turku 18
Chiswick 17
Berlin 16
Campinas 16
Auburn Hills 15
Hounslow 15
Curitiba 14
Salvador 14
Acton 13
Bologna 13
Dong Ket 13
Guarulhos 13
Jinhua 13
Porto Alegre 13
Phoenix 12
Istanbul 11
Quanzhou 11
Uberlândia 11
Wandsworth 11
Fuzhou 10
Hanover 10
Southwark 10
Stockholm 10
Edinburgh 9
Forlì 9
Fortaleza 9
Johannesburg 9
Nanjing 9
Pesaro 9
Sheffield 9
Simi Valley 9
Strasbourg 9
Tokyo 9
Warsaw 9
Totale 37.162
Salva come PNG Salva come JPEG
Nome #
Variation in reporting of cancer extent and benign histology in prostate biopsies among European pathologists. 205
Mitogen-activated protein kinases and apoptosis in PIN. 195
Handling and reporting of transurethral resection specimens of the bladder in Europe: a web-based survey by the European Network of Uropathology (ENUP). 192
Urothelial carcinoma with an inverted growth pattern can be distinguished from inverted papilloma by fluorescence in situ hybridization, immunohistochemistry, and morphologic analysis 188
Lymphoepithelioma-like carcinoma of the urinary bladder: a clinicopathologic study of 13 cases. 186
OCT4: biological functions and clinical applications as a marker of germ cell neoplasia 175
Morphometric index of adult renal cell carcinoma. Comparison with the Fuhrman grading system. 174
Prostatic Intraepithelial Neoplasia - Development of A Bayesian Belief Network For Diagnosis and Grading. 170
Designing novel immunocombinations in metastatic renal cell carcinoma 164
Transcontinental communication and quantitative digital histopathology via the Internet; with special reference to prostate neoplasia 146
Immunotherapy in genitourinary cancers: Where are we going? 139
Germline and somatic mutations in prostate cancer: Focus on defective DNA repair, PARP inhibitors and immunotherapy 133
Role of DNA analysis and mutation of P53 gene in small dimension renal carcinomas. Biological significance and long-term follow-up 131
Standardized mitotic counts in breast cancer evaluation of the method 127
Sequential or Concomitant Inhibition of Cyclin-Dependent Kinase 4/6 Before mTOR Pathway in Hormone-Positive HER2 Negative Breast Cancer: Biological Insights and Clinical Implications 127
Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients 126
The Role of Focal Therapy in the Management of Localised Prostate Cancer: A Systematic Review. 123
Activity and expression of nitric oxide synthase in rat bladder after sacral neuromodulation 123
Secondary neoplasms of the urinary system and male genital organs. 118
Computational analysis of the mutations in BAP1, PBRM1 and SETD2 genes reveals the impaired molecular processes in Renal Cell Carcinoma 117
Green fluorescent protein as indicator of non-viral transient transfection efficiency in endometrial and testicular biopsies 116
Chromosomal Abnormalities in Macroscopically Normal Urothelium in Patiens with Bladder pT1 and pT2a Urothelial Carcinoma: a Fluorescence in situ hybridisation Study and Correlation with Histologic Features. 116
Clinical performance and utility of a NNMT-based urine test for bladder cancer 116
Atypical foci, suspicious but not diagnostic of malignancy in prostate needle biopsies (also referred to as "atypical small acinar proliferation suspicious for but not diagnostic of malignancy") 114
Microbiome and cancers, with focus on genitourinary tumors 114
BAP1, PBRM1 and SETD2 in clear-cell renal cell carcinoma: Molecular diagnostics and possible targets for personalized therapies 112
Primary B-cell lymphoblastic lymphoma of the testis 111
Bone metastases in patients with metastatic renal cell carcinoma: Are they always associated with poor prognosis? 111
Prognostic value of CD44 expression in penile squamous cell carcinoma: a pilot study. 111
Metabolic phenotype of bladder cancer 111
Ciliary neurotrophic factor (CNTF) and its receptor (CNTFRα) signal through MAPK/ERK pathway in human prostate tissues: a morphological and biomolecular study 110
Biological issues with cabozantinib in bone metastatic renal cell carcinoma and castration-resistant prostate cancer 110
Computer assisted discrimination of glioblastomas 110
Nuclear changes in the normal-looking columnar epithelium adjacent to and distant from prostatic intraepithelial neoplasia and prostate cancer. Morphometric analysis in whole-mount sections. 107
Predicting future cancer burden in the United States by artificial neural networks 107
Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in clear cell renal cell carcinoma patients 106
HER2 expression and gene amplification in pT2a Gleason score 6 prostate cancer incidentally detected in cystoprostatectomies: comparison with clinically detected andreogen-dependent and androgen-independent cancer. 105
Expression of pi-class glutathione S-transferase: two populations of high grade prostatic intraepithelial neoplasia with different relations to carcinoma 105
Cytometric Evidence That Cervical Intraepithelial Neoplasia-i and Neoplasia-ii Are Dysplasias Rather Than True Neoplasias - An Image-analysis Study of Factors Involved In the Progression of Cervical Lesions 105
Prognostic role of tumor necrosis, microvessel density, vascular endothelial growth factor and hypoxia inducible factor-1 alpha in patients with clear cell renal carcinoma after radical nephrectomy in a long term follow-up 104
Morphologic Variants of Epithelial and Neuroendocrine Tumors of the Prostate. The Pathologist's Point of View 104
Exploring the Spectrum of Kidney Ciliopathies 103
alpha-methylacyl-CoA racemase (P504S)/34 beta E12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy 101
2004 WHO classification of the renal tumors of the adults. 101
Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications 101
Effect of complete androgen blockade on pathologic stage and resection margin status of prostate cancer: Progress pathology report of the Italian PROSIT study 100
Molecular diagnostics in uro-oncology 100
From undergraduate medical school student to visible pathologist 100
Immunohistochemical expression of somatostatin receptor subtypes in prostate tissue from cystoprostatectomies with incidental prostate cancer. 99
Do DNA methylation and histone acetylation play a role in clear cell renal carcinoma? Analysis of radical nephrectomy specimens in a long-term follow-up. 99
Seminal Vesicle Intraepithelial Neoplasia Versus Basal Cell Hyperplasia in a Seminal Vesicle. 98
Urothelial carcinoma of the bladder, lipid cell variant: clinicopathologic findings and LOH analysis 98
Cardiac myxoma with glandular elements metastatic to the brain 12 years after the removal of the original tumor 98
International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 1: specimen handling 98
Epithelial to Mesenchymal Transition in Renal Cell Carcinoma: Implications for Cancer Therapy 98
Oligometastases in Genitourinary Tumors: Recent Insights and Future Molecular Diagnostic Approach 98
Is There a Role for Immunotherapy in Prostate Cancer? 98
Interactive digital slides with heat maps: a novel method to improve the reproducibility of Gleason grading 97
Quantitative-analysis of Prostatic Intraepithelial Neoplasia On Tissue-sections. 97
D2-40 immunoreactivity in penile squamous cell carcinoma: a marker of aggressiveness 97
A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer. 97
Morphological diagnosis of urothelial neoplasms. 96
Metabolic Alterations in Renal and Prostate Cancer 96
Cognitive zonal fusion biopsy of the prostate: Original technique between target and saturation. 96
The 1996 European Urology Focus on Preneoplastic Lesions of the Prostate 96
Prognostic factors in stage T1 grade 3 bladder cancer survival: the role of G1-S modulators (p53, p21Waf1, p27kip1, Cyclin D1, and Cyclin D3) and proliferation index (ki67-MIB1) 95
Classification and grading of the non-invasive urothelial neoplasms: recent advances and controversies. 95
Succinate dehydrogenase-deficient renal cell carcinoma: Detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma 95
Pd-l1 inhibitors for the treatment of prostate cancer 95
Predicting biochemical recurrence after radical prostatectomy: the role of prognostic grade group and index tumor nodule 95
Urothelial lesions with inverted growth patterns: histogenesis, molecular genetic findings, differential diagnosis and clinical management 95
"Pathological" reflection on European urology: extended, saturation, and systematic prostate biopsies. 94
Editorial comment on: validation of the contemporary epstein criteria for insignificant prostate cancer in European men. 94
Perivascular epithelioid cell tumor (PEC-ome) of the prostate: ultrasound feature in case report 94
Urothelial papillary lesions. Development of a Bayesian Belief Network for diagnosis and grading 93
Computer assisted analysis of medulloblastoma: a cytological study 93
Activity of chemokines in prostate and renal tumors and their potential role as future therapeutic targets 93
Emerging prognostic biomarkers in testicular germ cell tumors: Looking beyond established practice 93
Grading of Chromophobe Renal Cell Carcinoma: Do We Need It? 93
Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvis 92
Improving inter-observer agreement and certainty level in diagnosing and grading papillary urothelial neoplasms: usefulness of a Bayesian belief network. 92
Biomarkers of aggressiveness in genitourinary tumors with emphasis on kidney, bladder, and prostate cancer 92
Combination therapy in advanced urothelial cancer: the role of PARP, HER-2 and mTOR inhibitors 92
Diagnostic Criteria for Ductal Adenocarcinoma of the Prostate.Interobserver Variability among 20 Expert Uropathologists. 92
Expert system support using a Bayesian belief network for the classification of endometrial hyperplasia 91
MRI and pathological examination of post-mortem brains: the problem of white matter high signal areas. 91
TGFb1 immunohistochemistry in goiter; comparison of patients with recurrence or non recurrence 91
Joint appraisal of the radical prostatectomy specimen by the urologist and the uropathologist: together, we can do it better 91
VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib 91
Autophagic Gene Polymorphisms in Liquid Biopsies and Outcome of Patients with Metastatic Clear Cell Renal Cell Carcinoma 91
Clinicopathologic analysis of upper urinary tract carcinoma with variant histology 91
A randomized phase IIb presurgical study of finasteride vs. low-dose flutamide vs. placebo in men with prostate cancer. Efficacy monitored by karyometry 91
[Gleason's grading of prostatic cancer: a current perspective]. 90
Aneuploidy and nuclear features of prostatic intraepithelial neoplasia (PIN). 90
Current and emerging bladder cancer biomarkers with an emphasis on urine biomarkers 90
Urothelial and incidental prostate carcinoma in prostates from cystoprostatectomies for bladder cancer: is there a relationship between urothelial and prostate cancer? 89
Basal cell hyperplasia and basal cell carcinoma of the prostate: a comprehensive review and discussion of a case with c-erbB-2 expression. 89
Pathology in prostate research: Optimizing tissue quality 89
HtrA1 in human urothelial bladder cancer: a secreted protein and a potential novel biomarker. 89
PD-1 blockade therapy in renal cell carcinoma: current studies and future promises 89
Totale 10.946
Salva come PNG Salva come JPEG
Categoria #
all - tutte 345.511
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 345.511
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.186 0 0 0 0 0 0 0 0 0 0 78 1.108
2020/202112.955 612 1.238 1.572 269 1.517 1.477 1.215 933 1.163 1.130 1.275 554
2021/20226.627 613 1.541 134 320 93 551 203 432 473 538 385 1.344
2022/202311.118 1.118 779 604 972 804 2.587 11 658 2.828 51 420 286
2023/20246.107 1.238 164 344 998 1.048 1.155 112 111 20 94 56 767
2024/202510.714 1.096 1.125 629 340 395 469 1.044 556 3.732 937 391 0
Totale 59.833